AU8598082A - Leukocyte adherence inhibition assay - Google Patents

Leukocyte adherence inhibition assay

Info

Publication number
AU8598082A
AU8598082A AU85980/82A AU8598082A AU8598082A AU 8598082 A AU8598082 A AU 8598082A AU 85980/82 A AU85980/82 A AU 85980/82A AU 8598082 A AU8598082 A AU 8598082A AU 8598082 A AU8598082 A AU 8598082A
Authority
AU
Australia
Prior art keywords
inhibition assay
leukocyte adherence
adherence inhibition
leukocyte
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU85980/82A
Inventor
Julius G. Bekesi
James F. Holland
Peter H. Tsang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai School of Medicine filed Critical Mount Sinai School of Medicine
Publication of AU8598082A publication Critical patent/AU8598082A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
AU85980/82A 1981-07-21 1982-07-13 Leukocyte adherence inhibition assay Abandoned AU8598082A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/285,587 US4455379A (en) 1981-07-21 1981-07-21 Leukocyte adherence inhibition assay
US285587 1981-07-21

Publications (1)

Publication Number Publication Date
AU8598082A true AU8598082A (en) 1983-01-27

Family

ID=23094897

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85980/82A Abandoned AU8598082A (en) 1981-07-21 1982-07-13 Leukocyte adherence inhibition assay

Country Status (7)

Country Link
US (1) US4455379A (en)
JP (1) JPS5873867A (en)
AU (1) AU8598082A (en)
BE (1) BE893900A (en)
CA (1) CA1186989A (en)
DK (1) DK307182A (en)
NL (1) NL8202945A (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0147689B1 (en) * 1983-12-05 1990-09-19 Asahi Kasei Kogyo Kabushiki Kaisha A method of inducing antitumor immunocytes, and a process for producing antitumor immunocytes and antitumor immunocytes produced by the process
US4716107A (en) * 1984-02-29 1987-12-29 Gross Robert L Method for diagnosis of A.I.D.S.
AU578661B2 (en) * 1984-02-29 1988-11-03 Dittmer, Thomas H. Method for diagnosis of A.I.D.S.
IT1204775B (en) * 1986-01-31 1989-03-10 Rosella Silvestrini KIT FOR THE DETERMINATION OF THE PROLIFERATIVE ACTIVITY IN HUMAN TUMORS
AU7696487A (en) * 1986-07-03 1988-01-29 Bio-Rad Laboratories, Inc. Peptide fragments of organ-specific neoantigens
US5279968A (en) * 1989-07-20 1994-01-18 Syncor International Corporation Method of labelling leucocytes with Tc-99m, d,1-HMPAO
US5900377A (en) * 1997-03-03 1999-05-04 Syncor International Corporation Method for isolating and radiolabeling leukocytes for use in vivo
CN114075545A (en) * 2020-08-11 2022-02-22 河南省肿瘤医院 Preparation method of antiviral specific T cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3999944A (en) * 1975-02-28 1976-12-28 Hoffmann-La Roche Inc. Detection of breast cancer
US4140753A (en) * 1976-04-30 1979-02-20 Scripps Clinic & Research Foundation Diagnostic method and reagent
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
US4311686A (en) * 1979-04-30 1982-01-19 The Immunology Development Corporation Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
US4294818A (en) * 1979-07-30 1981-10-13 University Patents, Inc. Methods and materials for detection of multiple sclerosis

Also Published As

Publication number Publication date
CA1186989A (en) 1985-05-14
DK307182A (en) 1983-01-22
JPS5873867A (en) 1983-05-04
NL8202945A (en) 1983-02-16
BE893900A (en) 1982-11-16
US4455379A (en) 1984-06-19

Similar Documents

Publication Publication Date Title
AU544724B2 (en) Peripheral systems
AU551769B2 (en) Imidazodiazepines
AU551891B2 (en) Imidazodiazepines
AU551756B2 (en) Imidazodiazepines
AU548397B2 (en) N-phenylsulphonyl-n:-pyrimidinyl-and-triazinyl-ureas
AU549409B2 (en) Polyetheresterimide
AU549410B2 (en) Polyetheresterimide
AU551508B2 (en) Displacement body
AU553589B2 (en) Benzoheterocycles
AU551831B2 (en) Imidazodiazepines
AU531893B2 (en) d
AU546185B2 (en) Levitationarium
AU555081B2 (en) Sulfonamides
AU547405B2 (en) Amidobenzamides
AU545678B2 (en) Sleeper-tamper
AU529966B2 (en) Washer-dehydrator
AU8598082A (en) Leukocyte adherence inhibition assay
AU552046B2 (en) Imidazodiazepines
AU527217B2 (en) d
AU547692B2 (en) Trifluoromethylphenyltetrahydropyridines
AU8497382A (en) d
AU8009482A (en) Halmbriketpresser
AU564363B2 (en) Repositionable fastener
AU547751B2 (en) Quinoline- and quinoxoline o-arylphosphetes
AU537889B2 (en) Sleeper-tamper